Financial Results
Samsung Biologics Reports First Quarter 2022 Financial Results
Samsung Biologics
PR-M04-22-14Apr 27, 2022
Automated Visual Inspection
Advancing Visual Inspection of Printed Pharmaceutical Materials
Florian Krickl; Stephen Makepeace-Warne
PAO-03-022-CL-24Mar 28, 2022
Column: New Drug Watch
Alzheimer Drug Still Controversial
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-022-NI-04Mar 23, 2022
Column: Technology
mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-02Mar 23, 2022
Recombinant Antibody Production
HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice
evitria AG
PAO-03-022-CL-22Mar 22, 2022
Biomanufacturing
Unique Vector Expression Technologies for Boosting Protein Production in E. coli
Trond Erik Vee Aune, Ph.D.
Vectron Biosolutions
PAO-02-022-CL-16Mar 20, 2022
Cell Culture
Changing the Future of Cell Culture and Accelerating Next-Generation Therapies
A.J. Mellott, Ph.D.; Scott Leigh
Ronawk
PAO-02-022-CL-20Mar 20, 2022
Gene Therapy Analytics
Overcoming Analytical Challenges for Gene Therapies
Jennifer Chadwick, Ph.D.
ProtaGene
PAO-02-022-CL-14Mar 20, 2022
COVID-19 Vaccines
Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-022-NI-05Mar 18, 2022
Remote Auditing
Will Remote Pharma GMP Auditing Continue Post-COVID?
Alasdair Leckie
PAO-02-022-CL-21Mar 16, 2022
Process Validation
Streamlining Process Validation for Drug Substance Manufacturing
Gerhard Noessner, Ph.D.; Juergen Utz, Ph.D.; Juergen Bank, Ph.D.
Fareva
PAO-02-022-CL-19Mar 15, 2022
Sterile
Sterile Injectables Device and Packaging Trends
James Grote
Nice Insight
PAO-02-022-NI-01Mar 14, 2022
Solubility
The Limitless Potential of Thin Film Freezing
Glenn Mattes
TFF Pharmaceuticals, Inc.
PAO-01-22-CL-04Mar 12, 2022
Neurodegenerative Diseases
Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases
Rob Etherington
PAO-01-22-CL-06Mar 12, 2022
Antibody Therapeutics
Developing New Antibody Therapeutics for COVID-19 and Beyond
Ian Chan
Abpro
PAO-01-22-CL-01Mar 12, 2022
Excipients
Enabling Stable, High-Viscosity Injectable Drug Products with New Excipient Combinations
Tobias Rosenkranz, Ph.D.; Sara Kalman
MilliporeSigma
PAO-01-22-CL-02Mar 12, 2022
Rare Disease Clinical Trials
Rare Disease Patients Benefit from Clinical Trial Flexibility
Tim Rich; Meredith McCumbee; Francis Jones, Ph.D.
PPD clinical research business of Thermo Fisher Scientific
PAO-02-022-CL-03Mar 12, 2022
COVID-19 Vaccines
The Global Immunization Disparity
Komal Hatti
IPS-Integrated Project Services, LLC
PAO-02-022-CL-04Mar 12, 2022
Viral Vector Manufacturing
Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing
Andrew Moreo; Lenore Giannunzio
Andelyn Biosciences
PAO-02-022-CL-01Mar 12, 2022
Oncology
Changing the Paradigm of Cancer Drug Discovery and Development with Plants
Martin Brenner, DVM, Ph.D.; Randy Maddux; Steven King
iBio, Inc.
PAO-02-022-CL-02Mar 12, 2022